Active Projects


Complete listing available on the NYU Health Sciences Library site.

Active Projects

  • R01NS098772
    CRMP2, Mitochondria, and Huntington Disease
    (Multi-PI; only the direct costs allocated to Khanna are shown)
    4/1/17  2/28/22

  • R01DA042852
    CRMP2, Nav1.7 Sodium Channel, and Chronic pain
    6/1/17  2/28/22

  • R01NS120663
    Genetic and Pharmacological Validation of CRMP2 Phosphorylation as a Novel therapeutic target for Neuropathic Pain
    8/1/20  7/31/24

  • R01NS120663-S1
    Sentrin Proteases, CRMP2 deSUMOylation, and Chronic Pain
    1/15/21  8/31/24

  • R01NS120663-S2
    CRMP2 Phosphorylation: A Novel Target for Alzheimer’s Disease
    4/15/21  7/31/24

  • R01NS119263
    Anti-CV2 Autoantibodies Unmask a CRMP5/GluN2B Pain Signaling Hub (co-I; only the direct costs allocated to Khanna are shown)
    1/1/20  12/21/25

  • R01AT009716
    Green Light Therapy for Chronic Pain
    (co-I; PI: Ibrahim)
    7/16/18  5/31/23

  • K08NS104272
    Mechanism of Intrathecal Contulakin-G Induced Analgesia Without Motor Block
    (co-I; PI: Patwardhan)
    7/15/18  4/30/23

  • R01AT009716-S1
    Green Light Therapy for Improving Dementia in Mice Models of Alzheimer’s Disease
    (co-I; 10% of grant costs allocated to Khanna)
    3/1/21  2/28/22

  • R01NS116694
    Validation of Spinal Neurotensin Receptor 2 as an Analgesic Target
    (co-I; PI: Patwardhan)
    9/15/20  8/31/24

  • R41CA257845
    Inhibition of CaVα-β Interaction with Orally Available Small Organic Molecules for Chronic Pain
    5/1/21  4/30/22

  • R41NS122545
    Targeting the Neuropilin-1 Receptor (NRP-1)/VEGF-A Axis for Neuropathic Pain
    7/1/21  6/30/23

  • 75N95019D00012
    Disease Model Characterization and Development of Assays to Evaluate and Measure Pain in a Porcine Model for Sickle Cell Disease
    10/1/19  6/30/22

    TAF1, T-Type channels, and X-linked Dystonia Parkinsonism, Collaborative Center for X-linked Dystonia Parkinsonism
    1/1/22  6/30/23

  • GEMM Award
    A NaV1.7 Mouse Lacking the CRMP2-binding Domain: Examining Specificity of NaV1.7-CRMP2 Coupling and Testing If Pain Resolution Requires Endogenous Opioid Signaling
    7/1/20  6/30/21

  • UA Venture Captial
    Optimization of Allosteric Regulators of the NaV1.7 Sodium Channel for Chemotherapy-induced Peripheral Neuropathy
    7/1/21  6/30/23

  • TLA Asset Development Award
    Blocking NRP-1 for the Treatment of Pain, Cancer and Prevention of Viral Entry
    5/1/21  4/30/23

  • Cariplo foundation (Italy)
    The Crucial Role of HCN2 Channels in Inflammatory and Neuropathic Pain
    1/1/21  12/30/23